• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX
Click for more information
4.76% 10.0¢

NOXOPHARM LIMITED - Charts / Financials

Market Cap $29.22M  ! watchlist Created with Sketch. Add to my watchlist

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel... Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 26/11/2024 (20 minute delay) ?
Day
Open 11.5¢   Day High 11.5¢   Day Low 10.0¢
Daily Volume 58010
Bids   Sellers
Number Price Volume   Number Price Volume
4 10.0¢ 42445   1 11.0¢ 14000

Directors & Senior Management

Ms. Gisela Mautner Chief Executive Officer, Executive Managing Director, Director
Mr. Shawn Van Boheemen Chief Financial Officer
Ms. Jeanette Bell Chief Operating Officer
Mr. David Franks Company Secretary
Mr. Frederick Bart Non-Executive Chairman of the Board
Mr. Peter Ashley Marks Non-Executive Deputy Chairman of the Board
Mr. Boris Patkin Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
10.0¢ 		Change
-0.005(4.76%) 		Mkt cap ! $29.22M
Open High Low Value Volume
11.5¢ 11.5¢ 10.0¢ $6.181K 58.01K

Buyers (Bids)

No. Vol. Price($)
4 42445 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 14000 1
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
Last
10.0¢ 		  Change
-0.005 ( 9.09 %)
Open High Low Volume
10.0¢ 10.0¢ 10.0¢ 2527
Last updated 15.59pm 26/11/2024 ?

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip Wealth Within chief analyst Dale Gillham and senior analyst Fil Tortevski have tipped $4.68 billion garbage giant Cleanaway Waste Management Limited (ASX:CWY) as their Hotcopper Hot Stock tip of the week @ especially because it seems to be slowly building towards a euphoric run akin to its mid 20...
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.